Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Resistance of subventricular neural stem cells to chronic hypoxemia despite structural disorganization of the germinal center and impairment of neuronal and oligodendrocyte survival.
The emerging role of p38 MAP kinase in multiple sclerosis and its models.
Progressive ataxia in a natalizumab-treated multiple sclerosis patient: the dark side of JC virus infection.
Myelin oligodendrocyte glycoprotein induces incomplete tolerance of CD4(+) T cells specific for both a myelin and a neuronal self-antigen in mice.
FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
Cognitive status in patients with multiple sclerosis in Lanzarote.
Autoimmunity in 2015.
Pediatric optic neuritis.
Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system.
In Vitro Effects of Sodium Benzoate on Th1/Th2 Deviation in Patients with Multiple Sclerosis.
Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis.
Teaching Video NeuroImages: Primary writing tremor: Lessons from a patient with multiple sclerosis.
Treatment of the osmotic demyelination syndrome: the earlier the better?
Intravenously infused F3.Olig2 improve memory deficit via restoring demyelination in the aged hippocampus following experimental ischemic stroke.
Effectiveness and safety of natalizumab in real-world clinical practice: Review of observational studies.
How have research questions and methods used in clinical trials published in Clinical Rehabilitation changed over the last 30 years?
Predictors of first-line treatment persistence in a Portuguese cohort of relapsing-remitting multiple sclerosis.
Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis.
Myelin-targeted, texaphyrin-based multimodal imaging agent for magnetic resonance and optical imaging.
Coping with multiple sclerosis-the role of social support.
Sunlight exposure: Do health benefits outweigh harm?
Shared decision-making in multiple sclerosis: A review.
Sensory information treatment during disturbed standing posture in chronic acquired demyelinating polyneuropathies (CADP).
IL-3 promotes the development of experimental autoimmune encephalitis.
Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder.
Pages
« first
‹ previous
…
741
742
743
744
745
746
747
748
749
…
next ›
last »